IL4 and systemic sclerosis: This paper shows, for the first time, an SSc specific effect of Zol, i.e., the enhancement of IL-4 secretion by PB Vδ1+ T cells, coupled with diminished ability of these cells to secrete IL-9 relative to two patients with another form of fibrosing disease, IPF.